Hyderabad firm working on a vaccine to provide protection against currently circulating variants of the virus
The vaccine is administered through intramuscular route with two doses scheduled 28 days apart.
World Health Organisation (WHO) has granted emergency use listing (EUL) for Corbevax, the Covid vaccine developed by Hyderabad-based vaccine maker Biological E.
India’s first indigenously developed Covid-19 vaccine based on protein sub-unit platform, Corbevax formed a part of the arsenal in the country’s fight against the deadly virus. The company had supplied 100 million doses to the government of India which then were utilised in pan-India immunization campaigns, mainly in 12-14 year old children, BE said announcing WHO’s EUL in a release on January 16.
No comments:
Post a Comment